polatuzumab vedotin-piiq
Used for Cancer
NowPatient helps you obtain your polatuzumab vedotin-piiq prescription for free or at low-cost. Drug savings programs are suitable for individuals who are insured, don't have insurance or are underinsured and can't afford your medicine.
Manufactured by various FDA-approved generic manufacturers.
*You can pay as little as $0 per fill using Drug Coupons or Patient Assistance Programs. Subject to applicability & eligibility requirements.
This content is intended for US audiences only
Start Saving Today!
Lower the cost of your polatuzumab vedotin-piiq prescription
Unavailable
N/AManufactured byN/APowered by
Canadian Prescription SavingsUnavailableUnavailable
Drug CouponsUnavailableUnavailable
Patient Assistance ProgramsUnavailable
polatuzumab vedotin-piiq key facts
What dosages is polatuzumab vedotin-piiq available in?
polatuzumab vedotin-piiq is available as a 30 mg or 140 mg single-dose vial.
What is polatuzumab vedotin-piiq used for?
polatuzumab vedotin-piiq is a CD79b-directed antibody and microtubule inhibitor conjugate indicated: In combination with a rituximab product, cyclophosphamide, doxorubicin, and prednisone (R-CHP) for the treatment of adult patients who have previously untreated diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL) and who have an International Prognostic Index score of 2 or greater. In combination with bendamustine and a rituximab product for the treatment of adult patients with relapsed or refractory DLBCL, NOS, after at least two prior therapies.
How does polatuzumab vedotin-piiq work?
polatuzumab vedotin-piiq works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
How do I take polatuzumab vedotin-piiq?
The recommended dose of polatuzumab vedotin-piiq is 1.8 mg/kg as an intravenous infusion every 21 days for 6 cycles.
Is it safe for me to take polatuzumab vedotin-piiq?
polatuzumab vedotin-piiq is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.
polatuzumab vedotin-piiq Common Side Effects
Common side effects of polatuzumab vedotin-piiq:
- Diarrhea
- Dizziness
- Loss of appetite
- Vomiting
- Weight loss
polatuzumab vedotin-piiq Serious Side Effects
Serious side effects are rare with polatuzumab vedotin-piiq. Side effects that you should report to your care team as soon as possible:
- Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
- Dizziness, loss of balance or coordination, confusion or trouble speaking
- Infection—fever, chills, cough, sore throat, wounds that don’t heal, pain or trouble when passing urine, general feeling of discomfort or being unwell
- Infusion reactions—chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded
Liver injury—right upper belly pain, loss of appetite, nausea, light-colored stool, dark yellow or brown urine, yellowing skin or eyes, unusual weakness or fatigue - Low red blood cell level—unusual weakness or fatigue, dizziness, headache, trouble breathing
- Pain, tingling, or numbness in the hands or feet
- Stomach pain, unusual weakness or fatigue, nausea, vomiting, diarrhea, or fever that lasts longer than expected
- Tumor lysis syndrome (TLS)—nausea, vomiting, diarrhea, decrease in the amount of urine, dark urine, unusual weakness or fatigue, confusion, muscle pain or cramps, fast or irregular heartbeat, joint pain
- Unusual bruising or bleeding
Effects of other drugs, drug classes and over-the-counter products on polatuzumab vedotin-piiq
The following medications may interact with polatuzumab vedotin-piiq:
- Concomitant use of strong CYP3A inhibitors or inducers has the potential to affect the exposure to unconjugated monomethyl auristatin E (MMAE)
Who makes polatuzumab vedotin-piiq?
Various FDA-approved generic manufacturers
Is polatuzumab vedotin-piiq safe in pregnancy?
polatuzumab vedotin-piiq can cause harm to your unborn baby when administered during pregnancy. You should take a pregnancy test prior to the initiation of polatuzumab vedotin-piiq. Females of reproductive potential to use effective contraception during treatment and for
3 months following the last dose of polatuzumab vedotin-piiq.
The FDA's medical product safety reporting program for health professionals, patients and consumers.
Learn more about reporting side effects in the USDrug Savings Guide
A practical guide to saving money and receiving support with prescription costs
How can NowPatient help me to lower the cost of my polatuzumab vedotin-piiq prescription?
After you create a FREE account with NowPatient, you will have access to 4 programs that can help lower the cost of your polatuzumab vedotin-piiq prescription
Applicability to each program will be dependent on your insurance status.
How do the NowPatient polatuzumab vedotin-piiq savings programs work?
After you have created your FREE account with NowPatient, you can access the various programs from your account dashboard. Each program has clear instructions on how to check your eligibility. You can see how the process works by clicking on the feature link below and seeing the ‘How it works’ steps.
Drug Coupon and Patient Assistance Programs require an eligibility quiz to be completed.
Are the NowPatient polatuzumab vedotin-piiq savings programs suitable for everyone, regardless of insurance status?
No. Each program has its own eligibility and applicability requirements. The table below shows if a program is available to you, based on your insurance status.
| Rx Advantage Card* for polatuzumab vedotin-piiq | Canadian Prescription Savings* for polatuzumab vedotin-piiq | polatuzumab vedotin-piiq Drug Coupon* | polatuzumab vedotin-piiq Patient Assistance Program* | |
| Insured (federal, state or government) | Available | Available | Not Available | Available If Offered by Pharmaceutical Company |
| Insured (Commercial or Private) | Available | Available | Available If Offered by Pharmaceutical Company | Available If Offered by Pharmaceutical Company |
| Uninsured | Available | Available | Not Available | Available If Offered by Pharmaceutical Company |
| Insured but without pharmacy benefit or drug coverage | Available | Available | Not Available | Available If Offered by Pharmaceutical Company |
*This is not insurance.
Are the NowPatient drug savings programs suitable for brand and generic versions of polatuzumab vedotin-piiq?
No. Each program has applicability requirements. Please see below
| Rx Advantage Card* for polatuzumab vedotin-piiq | Canadian Prescription Savings* for polatuzumab vedotin-piiq | polatuzumab vedotin-piiq Drug Coupon* | polatuzumab vedotin-piiq Patient Assistance Program* | |
| Brand | Yes | Yes | Yes, If Offered by Pharmaceutical Company | Yes, If Offered by Pharmaceutical Company |
| Generic | Yes | Yes | No | No |
*This is not insurance.
If you have Medicare Part D or Medicare Advantage and none of the polatuzumab vedotin-piiq savings options are applicable or affordable for me, what can you do?
If you are insured with Medicare and the polatuzumab vedotin-piiq drug savings options are not applicable to you and still remain unaffordable, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.
The government site is easy to use and after you have selected your state, it will navigate you to the appropriate contact point to make the application. State Medicaid programs may cover the full cost of your medication.
People who qualify for both Medicare and Medicaid are called ‘dual eligibles’.
If you are denied Medicaid for polatuzumab vedotin-piiq, and you are still unable to afford your copay or co-insurance element (for example if you are in the coverage gap or Donut Hole) then you may be eligible for a federal support program like Low Income Subsidy. To be eligible for Low Income Subsidy, you need to be a resident in one of the 50 States or the District of Columbia. You can check eligibility online at SSA Medicare D Extra Help. You can also call Social Security at 1-800-772-1213 (TTY 1-800-325-0778).
I am uninsured or underinsured and none of the polatuzumab vedotin-piiq prescription saving options are applicable or affordable for me, what can I do?
If you are uninsured or underinsured (for example, polatuzumab vedotin-piiq is not covered by your plan) and the drug savings options are not applicable or still unaffordable, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.
The government site is easy to use and you can select your state and it will navigate you to the appropriate contact point to make the application. State Medicaid programs may cover the full cost of your medication.
If you are denied and all else fails, and if you have been prescribed polatuzumab vedotin-piiq for an FDA-approved indication, you can call the pharmaceutical company to see if they have any other assistance programs.
I am commercially or privately insured and none of the polatuzumab vedotin-piiq prescription saving options are applicable or affordable for me, what can I do?
If your medication is not covered by your plan, you can appeal your insurance company’s decision. Sometimes, a formal appeal can result in the drug being covered if it is deemed medically necessary.
If you cannot afford your copay contribution, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.
However, being privately insured might complicate your eligibility for Medicaid, as having private insurance may be considered in the financial eligibility assessment.
The government site is easy to use and you can select your state and it will navigate you to the appropriate contact point to make the application. If you qualify, state Medicaid may cover the full cost of your medication.
If I have federal, state or commercial insurance and none of the polatuzumab vedotin-piiq prescription saving options are applicable or affordable for me, are there any other support organisations that can help me with my co-insurance or copay contributions?
If you have already tried Medicaid and received a denial letter or if you are insured with Medicare and have been denied Low-Income Subsidy, then you can try one of the following organizational support programs:
1. Patient Access Network Foundation (PAN) assistance for polatuzumab vedotin-piiq
If you are having trouble paying for your polatuzumab vedotin-piiq medication due to unaffordable copays or deductibles, the Patient Access Network Foundation (PAN), may be able to assist you. To qualify for PAN assistance for polatuzumab vedotin-piiq you will need to meet one or all of the following criteria:
- Your income is below 400% of the federal poverty level
- polatuzumab vedotin-piiq is prescribed for an approved FDA indication
- You live in and receive treatment in the United States or U.S. territories, even if you do not have U.S. citizenship
- You have Medicare insurance coverage that covers polatuzumab vedotin-piiq
- If polatuzumab vedotin-piiq is listed on PAN’s list of covered medications
You can check the Patient Access Network Foundation Website for more information.
2. HealthWell Foundation Copay Program for polatuzumab vedotin-piiq
If you are having trouble paying for your polatuzumab vedotin-piiq medication due to unaffordable copays or deductibles, the HealthWell Foundation Copay Program may be able to assist you. To qualify for assistance for polatuzumab vedotin-piiq you will need to meet the following criteria:
- You live in and are being treated in the United States
- You are insured and your plan covers polatuzumab vedotin-piiq
- If polatuzumab vedotin-piiq is listed on the HealthWell Foundation’s list of covered medications
You can check the HealthWell Foundation Website for more information.
3. Patient Advocate Foundation Co-Pay Relief Program for polatuzumab vedotin-piiq
Patient Advocate Foundation’s Co-Pay Relief program exists to help reduce the financial distress you or your family may face when paying for your polatuzumab vedotin-piiq treatment. If you qualify and can demonstrate the need, the foundation will provide you with direct payment covering co-pays, co-insurance, and deductibles. To qualify for assistance for polatuzumab vedotin-piiq you will need to meet the following criteria:
- You must be currently insured and have coverage for polatuzumab vedotin-piiq
- You must have a confirmed diagnosis and treatment plan
- You must reside and receive treatment in the United States
- Your Income must fall at or below 300% or 400% of the Federal Poverty Guideline (FPG) with consideration for the Cost of Living Index (COLI) and number in the household
- Applications can also be completed by contacting the program sponsor, toll-free at 866-512-3861.
You can check the Patient Advocate Foundation Website for more information.
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Can I Trust NowPatient
Our product and services are certified to international healthcare, medical device and data security standards
WHY WE BUILT NOWPATIENT
We are committed to helping everyone, everywhere live healthier lives
The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
